Riskpilot← Back to searchSign inGet full accessSENTRAL PERIO 2 AS
ASActiveOrg 918263489Fosenkaia 3, 7010 TrondheimDental practice care activities · NACE 8623Est. 20162 employees
Revenue 2022
NOK 3,8M
-4% vs 2021
EBITDA margin
1.3%
-60% vs 2021
Equity ratio
24.6%
Financial strength
Net profit 2022
NOK 20K
+189% vs 2021
| Revenue | NOK 3,8M | -4% |
| EBITDA | NOK 52K | -60% |
| Net profit | NOK 20K | +189% |
| Total assets | NOK 687K | -11% |
| Equity | NOK 169K | +13% |
| Employees | 2 | — |
Legal name
SENTRAL PERIO 2 AS
Org number
918263489
Legal form
Aksjeselskap
NACE code
8623 · Dental practice care activities
Founded
16. desember 2016
Share capital
NOK 120 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Spesialisert tannlegebehandling.
Address
Fosenkaia 3, 7010 Trondheim
Phone
+4773534536
Email
post@sentraldental.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 5 468 | 4 088 | 3 529 | 3 973 | 3 822 |
| Staff expenses | −701 | −786 | −564 | −793 | −873 |
| EBITDA | 148 | 134 | 126 | 128 | 52 |
| Depreciation & amort. | −96 | −108 | −108 | −108 | −31 |
| EBIT | 52 | 27 | 19 | 20 | 20 |
| Net financials | −32 | −7 | 0 | −0 | −0 |
| Profit before tax | 20 | 20 | 19 | 20 | 20 |
| Tax | 7 | 5 | 3 | 42 | −0 |
| Net profit | 13 | 15 | 16 | −22 | 20 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 1 423 | 1 159 | 769 | 772 | 687 |
| Equity | 141 | 156 | 172 | 150 | 169 |
| Long-term debt | 760 | 569 | 503 | 280 | 188 |
| Short-term debt | 522 | 433 | 94 | 343 | 342 |
| Total debt | 1 282 | 1 003 | 597 | 623 | 530 |
EBITDA margin
1.3%
This company
15.8%
Market median
-92% vs market
20182022
Equity ratio
24.6%
This company
38.2%
Market median
-36% vs market
20182022
Return on equity
11.6%
This company
18.4%
Market median
+37% vs market
20182022
Net profit margin
0.5%
This company
8.1%
Market median
-94% vs market
20182022
Asset turnover
5.56×
This company
1.12×
Market median
+396% vs market
20182022
Debt / equity
3.06×
This company
0.62×
Market median
-394% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
OI Chief Executive Officer | Chief Executive Officer | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Former (1) | ||
| Chairman | 2016 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 | |
| Company | 50% | 50% | 2023 | |
| Company | 50% | 50% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dente 2 As
SENTRAL PERIO 2 AS Board members of SENTRAL PERIO 2 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Olav Inge Larsen | Chief Executive Officer | 0 companies |
| Daniel Holck | Chairman | 0 companies |
| Silje Drege Løfsnæs | Board of Directors | 0 companies |
| Eivind Skaar | Chairman | 0 companies |
| Lill Bente Skei | Board of Directors | 0 companies |